Variant report
| Variant | esv2761352 |
|---|---|
| Chromosome Location | chr7:102843462-102869010 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs531954943 | chr7:102850617-102850618 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 2 | rs185782967 | chr7:102850618-102850619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs190309626 | chr7:102850634-102850635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs562030792 | chr7:102850657-102850658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs536326549 | chr7:102850684-102850685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 6 | rs527816032 | chr7:102850697-102850698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs568779548 | chr7:102850716-102850717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs17136078 | chr7:102850726-102850727 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 9 | rs567840520 | chr7:102850739-102850740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs538066823 | chr7:102850786-102850787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs556846796 | chr7:102850812-102850813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs578254782 | chr7:102850821-102850822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 13 | rs538998623 | chr7:102850911-102850912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs554191102 | chr7:102850916-102850917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs62481612 | chr7:102850931-102850932 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 16 | rs181038848 | chr7:102850949-102850950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 17 | rs561265552 | chr7:102850967-102850968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 18 | rs17136079 | chr7:102850993-102850994 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 19 | rs11560368 | chr7:102850994-102850995 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 20 | rs564802859 | chr7:102851066-102851067 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 21 | rs202062307 | chr7:102851077-102851078 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 22 | rs369789520 | chr7:102851094-102851095 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 23 | rs145022643 | chr7:102851112-102851113 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 24 | rs147974399 | chr7:102851114-102851115 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 25 | rs146108365 | chr7:102851116-102851117 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 26 | rs368364671 | chr7:102851118-102851119 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 27 | rs57525870 | chr7:102851119-102851120 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 28 | rs57341369 | chr7:102851136-102851137 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 29 | rs202042584 | chr7:102851161-102851162 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 30 | rs201697098 | chr7:102851163-102851164 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 31 | rs530741377 | chr7:102851164-102851165 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 32 | rs577686035 | chr7:102851177-102851178 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 33 | rs545186447 | chr7:102851219-102851220 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 34 | rs374151172 | chr7:102851229-102851230 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 35 | rs547502993 | chr7:102851234-102851235 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 36 | rs569652794 | chr7:102851241-102851242 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 37 | rs538404647 | chr7:102851265-102851266 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 38 | rs550411713 | chr7:102851273-102851274 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 39 | rs139313350 | chr7:102851285-102851286 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 40 | rs112071667 | chr7:102851288-102851289 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 41 | rs112979910 | chr7:102851297-102851298 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 42 | rs539316920 | chr7:102851321-102851322 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 43 | rs554550975 | chr7:102851323-102851324 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 44 | rs572395519 | chr7:102851332-102851333 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 45 | rs62481613 | chr7:102851384-102851385 | Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 46 | rs555020818 | chr7:102851431-102851432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 47 | rs576476330 | chr7:102851461-102851462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 48 | rs543546478 | chr7:102851463-102851464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 49 | rs564717298 | chr7:102851469-102851470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 50 | rs11560369 | chr7:102851471-102851472 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| Disease | PMID | Source |
|---|---|---|
| Basal cell lymphoma | 17170743 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Thyroid cancer | 19087340 | CNVD |
| Seminomas | 18059402 | CNVD |
| Testicular cancer | 18059402 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Autism | 19415332 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
| T-cell lymphomas | 19863542 | CNVD |
| Malaria | 21533027 | CNVD |
| Melanoma | 18172304 | CNVD |
| Renal cell carcinoma | 19461508 | CNVD |
| head and neck squamous cell carcinoma | 19289630 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Ewing''s sarcoma | 17952124 | CNVD |
| Autism | 22495311 | CNVD |
| Wilms tumour | 21544195 | CNVD |
| Non-small cell lung cancer | 21829676 | CNVD |
| Gastric cancer | 24379144 | CNVD |
| Glioblastoma multiforme | 17002787 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Lissencephaly | 21572526 | CNVD |
| Breast cancer | 17603634 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Breast cancer | 16397240 | CNVD |
| Acute myeloid leukemia | 16864856 | CNVD |
| Squamous cell cancer | 21044232 | CNVD |
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
| Astrocytoma | 17387387 | CNVD |
| Glioblastoma multiforme | 17387387 | CNVD |
| Low-grade fibromyxoid sarcoma | 0 | CNVD |
| Oligodendroglial tumors | 17285580 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Burkitt''s lymphoma | 18698080 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Shwachman-Diamond syndrome | 22934832 | CNVD |
| Colorectal cancer | 19359472 | CNVD |
| Cutaneous malignant melanoma | 17690212 | CNVD |
| Leukemia | 17361228 | CNVD |
| Breast cancer | 16461572 | CNVD |
| Peripheral t-cell lymphoma | 19118030 | CNVD |
| Malignant melanoma | 17690212 | CNVD |
| Renal cell carcinoma | 18592004 | CNVD |
| Acute promyelocytic leukemia | 19109227 | CNVD |
| Multiple myeloma | 17550852 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Neurodevelopmental disorder | 22521361 | CNVD |
| abortions and stillbirths | 19751515 | CNVD |
| Acute lymphoblastic leukemia | 21980252 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Metanephric adenoma | 20802469 | CNVD |
| Prostate cancer | 16461572 | CNVD |
| Endometrioid adenocarcinoma | 16974079 | CNVD |
| Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
| Burkitt''s lymphoma | 19759907 | CNVD |
| Malignant melanoma | 17260012 | CNVD |
| Myelodysplastic syndrome | 21251322 | CNVD |
| Acute myeloid leukemia | 21251322 | CNVD |
| Breast cancer | 21785460 | CNVD |
| Chronic myeloid leukemia | 21384125 | CNVD |
| Bladder cancer | 21909424 | CNVD |
| Biliary cancer | 19435499 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Splenic marginal zone lymphoma | 21957467 | CNVD |
| Breast cancer | 16608533 | CNVD |
| Primary central nervous system lymphoma | 21088137 | CNVD |
| Liver carcinoma | 19366792 | CNVD |
| T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
| Adenocarcinoma | 19607727 | CNVD |
| Multiple myeloma | 16461302 | CNVD |
| Breast cancer | 21858162 | CNVD |
| Emphysema | 19352772 | CNVD |
| Effusion lymphoma | 18079361 | CNVD |
| Medulloblastoma | 17653508 | CNVD |
| Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
| Autism | 19401682 | CNVD |
| Neuroticism | 17667963 | CNVD |
| Prostate cancer | 18632612 | CNVD |
| Acute lymphoblastic leukemia | 22237106 | CNVD |
| Cancer | 19907438 | CNVD |
| Breast cancer | 21364760 | CNVD |
| abnormal development | 18461090 | CNVD |
| Pancreatic cancer | 17952125 | CNVD |
| Glioblastoma multiforme | 21510904 | CNVD |
| Cancer | 20164919 | CNVD |
| Breast cancer | 22522925 | CNVD |
| Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr7:102850600-102850800 | Weak transcription | Fetal Lung | lung |
| 2 | chr7:102850800-102851000 | Enhancers | Fetal Lung | lung |
| 3 | chr7:102851000-102851400 | Flanking Active TSS | Fetal Lung | lung |
| 4 | chr7:102851200-102851800 | Enhancers | K562 | blood |
| 5 | chr7:102863800-102864000 | Enhancers | GM12878-XiMat | blood |
| 6 | chr7:102864000-102866400 | Weak transcription | GM12878-XiMat | blood |
| 7 | chr7:102865800-102867200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
| 8 | chr7:102866400-102867000 | Enhancers | GM12878-XiMat | blood |
| 9 | chr7:102867200-102871800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |






